Daniel Geffken

Daniel Geffken Email and Phone Number

Founder and Managing Director @ Danforth Advisors
Cambridge, MA, US
Daniel Geffken's Location
Cambridge, Massachusetts, United States, United States
About Daniel Geffken

Daniel Geffken is a Founder and Managing Director at Danforth Advisors.

Daniel Geffken's Current Company Details
Danforth Advisors

Danforth Advisors

View
Founder and Managing Director
Cambridge, MA, US
Daniel Geffken Work Experience Details
  • Danforth Advisors
    Founder And Managing Director
    Danforth Advisors
    Cambridge, Ma, Us
  • Danforth Advisors
    Founder And Managing Director
    Danforth Advisors Aug 2011 - Present
    Waltham, Massachusetts, Us
    Danforth Advisors partners with life science companies to help them start, grow and successfully operate towards their best possible outcomes. We advise and execute in the areas of finance, accounting and operations, providing specialized services that are informed by industry perspective and carried out by consultants who are experienced in this uniquely challenging space. Founded in 2011, we have been a strategic and trusted thought partner to hundreds of life science companies, private and public, across all stages of the corporate life cycle.
  • Eloxx Pharmaceuticals
    Interim Chief Financial Officer
    Eloxx Pharmaceuticals Apr 2021 - Present
    Watertown, Massachusetts, Us
  • Olaris, Inc
    Senior Financial Advisor
    Olaris, Inc Mar 2021 - Present
    Framingham, Massachusetts, Us
  • Locust Walk Acquisition Corp.
    Chief Financial Officer
    Locust Walk Acquisition Corp. Dec 2020 - Present
  • Affini-T
    Senior Financial Advisor
    Affini-T Feb 2021 - Present
  • Myeloid Therapeutics
    Senior Financial Advisor
    Myeloid Therapeutics Feb 2021 - Present
    Cambridge, Massachusetts, Us
  • Century Therapeutics, Llc
    Senior Financial Advisor
    Century Therapeutics, Llc Jan 2021 - Present
    Philadelphia, Pennsylvania, Us
  • Calcimedica
    Interim Chief Financial Officer
    Calcimedica Nov 2020 - Present
    La Jolla, California, Us
  • Dermbiont Therapeutics
    Interim Chief Financial Officer
    Dermbiont Therapeutics Oct 2020 - Present
  • Matrivax Corporation
    Senior Financial Advisor
    Matrivax Corporation Jan 2020 - Present
    Boston, Massachusetts, Us
  • Prilenia
    Senior Financial Advisor
    Prilenia Mar 2020 - Present
    Boston, Massachusetts, Us
  • Nia Therapeutics
    Senior Financial Advisor
    Nia Therapeutics Mar 2018 - Present
  • Apic Bio, Inc.
    Interim Chief Financial Officer
    Apic Bio, Inc. Mar 2018 - Present
  • Antolrx, Inc.
    Interim Chief Financial Officer
    Antolrx, Inc. Jun 2016 - Present
  • Elicio Therapeutics
    Interim Chief Financial Officer And Director
    Elicio Therapeutics Apr 2014 - Present
    Boston, Massachusetts, Us
  • Promis™ Neurosciences, Inc.
    Chief Financial Officer
    Promis™ Neurosciences, Inc. Nov 2016 - Present
    Toronto, Ontario, Ca
  • Palvella Therapeutics
    Senior Financial Advisor
    Palvella Therapeutics Aug 2020 - Present
  • Bionaut Labs
    Interim Chief Financial Officer
    Bionaut Labs May 2021 - Sep 2022
    Los Angeles, Ca, Us
  • Acrivon Therapeutics, Inc.
    Senior Financial Advisor
    Acrivon Therapeutics, Inc. Mar 2021 - Aug 2022
    Cambridge, Massachusetts, Us
  • Vigeo Therapeutics
    Interim Chief Financial Officer
    Vigeo Therapeutics Nov 2017 - Mar 2022
  • Zikani Therapeutics
    Interim Chief Financial Officer
    Zikani Therapeutics Jul 2019 - Mar 2021
  • Privo Technologies Inc
    Interim Chief Financial Officer
    Privo Technologies Inc Mar 2020 - Jan 2021
    Peabody, Massachusetts, Us
  • Graybug Vision, Inc.
    Senior Financial Advisor
    Graybug Vision, Inc. Sep 2019 - Oct 2020
  • Atea Pharmaceuticals
    Interim Chief Financial Officer
    Atea Pharmaceuticals Jul 2019 - Sep 2020
  • Lysosomal Technologies, Inc.
    Interim Chief Financial Officer
    Lysosomal Technologies, Inc. Jul 2013 - Jul 2020
  • Promedior, Inc
    Interim Chief Financial Officer
    Promedior, Inc May 2012 - Mar 2020
  • Cabaletta Bio
    Senior Financial Advisor
    Cabaletta Bio Apr 2018 - Dec 2019
    Philadelphia, Pennsylvania, Us
  • Aquinnah Pharmaceuticals
    Interim Chief Financial Officer
    Aquinnah Pharmaceuticals Dec 2017 - Dec 2019
  • Kallyope, Inc.
    Senior Financial Advisor
    Kallyope, Inc. Sep 2015 - Dec 2019
    Kalllyope announced in December 2015 a $40M Series A. Congratulations.
  • Stealth Biotherapeutics
    Interim Chief Financial Officer
    Stealth Biotherapeutics Nov 2016 - May 2019
    Needham, Massachusetts, Us
  • Lyra Therapeutics
    Senior Financial Advisor
    Lyra Therapeutics Nov 2015 - Apr 2019
    Watertown, Massachusetts, Us
  • Immunsant
    Senior Financial Advisor
    Immunsant Oct 2018 - Mar 2019
  • Stoke Therapeutics
    Senior Financial Advisor
    Stoke Therapeutics Oct 2015 - Feb 2019
  • Recover Together (Dba, Groups, Inc.)
    Interim Chief Financial Officer
    Recover Together (Dba, Groups, Inc.) Aug 2017 - Sep 2018
  • Pear Therapeutics
    Senior Financial Advisor
    Pear Therapeutics Apr 2016 - Sep 2018
  • Entrada Therapeutics, Inc.
    Interim Chief Financial Officer
    Entrada Therapeutics, Inc. Sep 2016 - Aug 2018
  • Vyriad, Inc.
    Member Board Of Directors
    Vyriad, Inc. Sep 2016 - Jul 2018
    Leader in the development of oncolytic viruses.
  • Genepeeks, Inc.
    Interim Chief Financial Officer
    Genepeeks, Inc. Aug 2015 - Jun 2018
  • Immuneering Corporation
    Senior Financial Advisor
    Immuneering Corporation Oct 2014 - Jun 2018
    Cambridge, Ma, Us
  • Arcturus Therapeutics
    Board Of Directors
    Arcturus Therapeutics Nov 2017 - May 2018
  • Opsonix, Inc.
    Interim Chief Financial Officer
    Opsonix, Inc. Jul 2015 - May 2018
  • Opsonix, Inc.
    Interim Chief Financial Officer
    Opsonix, Inc. Jun 2015 - May 2018
  • Elucida Oncology, Inc.
    Senior Financial Advisor
    Elucida Oncology, Inc. Nov 2017 - Jan 2018
  • Apellis Pharmaceuticals
    Interim Chief Financial Officer
    Apellis Pharmaceuticals Aug 2015 - Oct 2017
    Waltham, Ma, Us
  • Alcobra Ltd
    Board Of Directors; Audit Committee, Compensation Committee
    Alcobra Ltd May 2013 - Oct 2017
    Alcobra Ltd., founded in 2008 and headquartered in Tel Aviv, Israel, is an emerging pharmaceutical company focused on the development of new medications to help patients with cognitive disorders including Attention Deficit Hyperactivity Disorder (ADHD) and Fragile X Syndrome. Metadoxine Extended Release (MDX) is the company’s lead investigational product candidate. Alcobra trades under the symbol “ADHD” on the NASDAQ Capital Market and the company completed its initial public offering on May 21, 2013. In addition to its headquarters in Tel Aviv, Alcobra has a U.S. office located outside of Philadelphia in Plymouth Meeting, Pennsylvania.
  • Wntrx Pharmaceuticals
    Senior Financial Advisor
    Wntrx Pharmaceuticals Nov 2016 - Jun 2017
  • Cidara Therapeutics
    Senior Financial Advisor
    Cidara Therapeutics Jan 2013 - Jun 2017
    San Diego, Ca, Us
  • Homology Medicines, Inc.
    Interim Chief Financial Officer
    Homology Medicines, Inc. May 2015 - Mar 2017
  • Ideaya Biosciencs
    Senior Financial Advisor
    Ideaya Biosciencs Aug 2015 - Dec 2016
    South San Francisco, California, Us
  • Gamida Cell
    Senior Finanical Advisor
    Gamida Cell Apr 2016 - Oct 2016
    Boston, Massachusetts, Us
  • Chiasma, Inc.
    Senior Financial Advisor
    Chiasma, Inc. Jan 2015 - Jun 2016
  • Marina Biotech, Inc.
    Interim Chief Financial Officer
    Marina Biotech, Inc. Jan 2014 - Jun 2016
    City Of Industry, Ca, Us
    Provide interim financial services to publicly traded mRNA company.
  • Alcresta, Inc.
    Senior Financial Advisor
    Alcresta, Inc. Oct 2014 - Dec 2015
  • X4 Therapeutics
    Interim Chief Financial Officer
    X4 Therapeutics Mar 2015 - Nov 2015
  • New England Venture Capital Association
    Interim Chief Financial Officer
    New England Venture Capital Association Aug 2013 - Nov 2015
    Boston, Ma, Us
  • Altimmune, Inc.
    Senior Financial Advisor
    Altimmune, Inc. Mar 2015 - Oct 2015
    Gaithersburg, Maryland, Us
  • Gelesis
    Senior Financial Advisor
    Gelesis Sep 2014 - Aug 2015
    Boston, Ma, Us
  • Editas Medicine
    Interim Chief Financial Officer
    Editas Medicine Sep 2013 - Jul 2015
    Cambridge, Massachusetts, Us
  • H3 Biomedicine
    Senior Financial Advisor
    H3 Biomedicine Feb 2015 - Jun 2015
  • Anchor Therapeutics
    Senior Financial Advisor
    Anchor Therapeutics Mar 2012 - Mar 2015
    Through Danforth Advisors, we provide operational and financial consulting services.
  • Sideris Pharmaceuticals
    Chief Financial Officer
    Sideris Pharmaceuticals Dec 2012 - Jan 2015
  • Genocea Biosciences
    Senior Financial Consultant
    Genocea Biosciences Jun 2012 - Sep 2014
  • Novira Therapeutics
    Interim Chief Financial Officer
    Novira Therapeutics Aug 2012 - Jun 2014
  • Living Proof, Inc.
    Senior Financial Consultant
    Living Proof, Inc. Aug 2013 - Dec 2013
    Boston, Ma, Us
    Developed strategic financial plan for prestige brand beauty products company, founded on MIT technology.
  • Usds, Inc.
    Interim Chief Financial Officer
    Usds, Inc. Jul 2011 - Sep 2013
  • Bionostics, Inc
    Interim Cfo
    Bionostics, Inc Jun 2012 - Aug 2013
  • Acusphere
    Strategic Advisor
    Acusphere Feb 2012 - Jun 2013
    Through Danforth Advisors, I provide financial strategy consulting and fundraising assistance.
  • Infobionic, Inc.
    Strategic Advisor
    Infobionic, Inc. Feb 2012 - Dec 2012
  • Algeta Us, Llc
    Senior Advisor, Finance And Operations
    Algeta Us, Llc Mar 2012 - Nov 2012
    Oslo, No
    Through Danforth Advisors, I lead senior advisory services in the areas of finance, operations and human resources. Algeta is a publicly-traded Norwegian biotechnology company that is establishing a US sale subsidiary.
  • Seaside Therapeutics
    Chief Operating Officer
    Seaside Therapeutics Aug 2009 - Feb 2011
    Us
    Seaside Therapeutics is creating new drug treatments to correct or improve the course of Fragile X Syndrome, autism and other disorders of brain development. We are dedicated to translating breakthrough discoveries in neurobiology into therapeutics that improve the lives of patients and their families.
  • Daniel Geffken Consulting, Llc
    Principal
    Daniel Geffken Consulting, Llc 2008 - Aug 2009
    Daniel Geffken Consulting provides financial leadership and strategy consulting to companies in the life sciences and renewable energy industries.
  • Codon Devices
    Chief Financial Officer
    Codon Devices 2006 - 2008
  • Konarka Technologies
    Evp, Chief Financial Officer
    Konarka Technologies 2006 - 2007
    Us
  • Omnisonics Medical Technologies
    Svp, Chief Financial Officer
    Omnisonics Medical Technologies 2003 - 2006
    Us
  • Transkaryotic Therapies, Inc.
    Svp, Chief Financial Officer
    Transkaryotic Therapies, Inc. Jan 1997 - Apr 2003
  • Cytotherpeutics, Inc.
    Vp, Chief Financial Officer
    Cytotherpeutics, Inc. 1993 - 1997
  • Medchem Products
    Chief Financial Officer
    Medchem Products 1989 - 1991
  • Kpmg Us
    Senior Audit Manager
    Kpmg Us 1979 - 1985
    New York, Ny, Us

Daniel Geffken Education Details

  • Harvard Business School
    Harvard Business School
    Mba
  • The Wharton School
    The Wharton School
    Economics

Frequently Asked Questions about Daniel Geffken

What company does Daniel Geffken work for?

Daniel Geffken works for Danforth Advisors

What is Daniel Geffken's role at the current company?

Daniel Geffken's current role is Founder and Managing Director.

What schools did Daniel Geffken attend?

Daniel Geffken attended Harvard Business School, The Wharton School.

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant

Download 750 million emails and 100 million phone numbers

Access emails and phone numbers of over 750 million business users. Instantly download verified profiles using 20+ filters, including location, job title, company, function, and industry.